These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 30838608)
1. Histidine-Rich Cationic Cell-Penetrating Peptides for Plasmid DNA and siRNA Delivery. Kichler A; Mason AJ; Marquette A; Bechinger B Methods Mol Biol; 2019; 1943():39-59. PubMed ID: 30838608 [TBL] [Abstract][Full Text] [Related]
2. Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery. Kichler A; Mason AJ; Marquette A; Bechinger B Methods Mol Biol; 2013; 948():85-103. PubMed ID: 23070765 [TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870 [TBL] [Abstract][Full Text] [Related]
4. Histidine-rich designer peptides of the LAH4 family promote cell delivery of a multitude of cargo. Moulay G; Leborgne C; Mason AJ; Aisenbrey C; Kichler A; Bechinger B J Pept Sci; 2017 Apr; 23(4):320-328. PubMed ID: 28067008 [TBL] [Abstract][Full Text] [Related]
5. Design of a new cell penetrating peptide for DNA, siRNA and mRNA delivery. Ali S; Dussouillez C; Padilla B; Frisch B; Mason AJ; Kichler A J Gene Med; 2022 Mar; 24(3):e3401. PubMed ID: 34856643 [TBL] [Abstract][Full Text] [Related]
6. Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways. Lam JK; Liang W; Lan Y; Chaudhuri P; Chow MY; Witt K; Kudsiova L; Mason AJ J Control Release; 2012 Mar; 158(2):293-303. PubMed ID: 22138072 [TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids. Kato T; Yamashita H; Misawa T; Nishida K; Kurihara M; Tanaka M; Demizu Y; Oba M Bioorg Med Chem; 2016 Jun; 24(12):2681-7. PubMed ID: 27132868 [TBL] [Abstract][Full Text] [Related]
8. Peptide vectors for the nonviral delivery of nucleic acids. Hoyer J; Neundorf I Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499 [TBL] [Abstract][Full Text] [Related]
9. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Mo RH; Zaro JL; Shen WC Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592 [TBL] [Abstract][Full Text] [Related]
10. pH-Dependent Membrane Interactions of the Histidine-Rich Cell-Penetrating Peptide LAH4-L1. Wolf J; Aisenbrey C; Harmouche N; Raya J; Bertani P; Voievoda N; Süss R; Bechinger B Biophys J; 2017 Sep; 113(6):1290-1300. PubMed ID: 28734478 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery. Dohmen C; Wagner E Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of a Nuclear Localization Signal in pH Responsive LAH4-L1 Peptide Enhances Transfection and Nuclear Uptake of Plasmid DNA. Xu Y; Liang W; Qiu Y; Cespi M; Palmieri GF; Mason AJ; Lam JK Mol Pharm; 2016 Sep; 13(9):3141-52. PubMed ID: 27458925 [TBL] [Abstract][Full Text] [Related]
13. Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation. Åmand HL; Nordén B; Fant K Biochem Biophys Res Commun; 2012 Feb; 418(3):469-74. PubMed ID: 22281502 [TBL] [Abstract][Full Text] [Related]
14. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform. Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226 [TBL] [Abstract][Full Text] [Related]
15. Intracellular Delivery of Plasmid DNA Using Amphipathic Helical Cell-Penetrating Peptides Containing Dipropylglycine. Naka M; Umeno T; Shibuya M; Yamaberi Y; Ueda A; Tanaka M; Takemoto H; Oba M Chem Pharm Bull (Tokyo); 2024; 72(5):512-517. PubMed ID: 38811213 [TBL] [Abstract][Full Text] [Related]
16. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system. Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163 [TBL] [Abstract][Full Text] [Related]
17. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery. Upadhya A; Sangave PC J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187 [TBL] [Abstract][Full Text] [Related]
18. Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid. Layek B; Lipp L; Singh J Int J Mol Sci; 2015 Dec; 16(12):28912-30. PubMed ID: 26690119 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficiency of complexes based on S4(13)-PV cell-penetrating peptides in plasmid DNA and siRNA delivery. Cardoso AM; Trabulo S; Cardoso AL; Maia S; Gomes P; Jurado AS; Pedroso de Lima MC Mol Pharm; 2013 Jul; 10(7):2653-66. PubMed ID: 23697649 [TBL] [Abstract][Full Text] [Related]
20. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells. Furukawa K; Tanaka M; Oba M Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]